Karen M. Dahut - Aug 11, 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Karen M Dahut
Stock symbol
DXCM
Transactions as of
Aug 11, 2022
Transactions value $
$3
Form type
4
Date filed
5/22/2023, 03:45 PM
Previous filing
Jul 5, 2022
Next filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Gift $0 -1.55K -21.99% $0.00 5.49K Aug 11, 2022 Direct F1
transaction DXCM Common Stock Award $2.91 +2.91K +52.91% $0.00* 8.4K May 18, 2023 Direct F2
transaction DXCM Common Stock Gift $0 -3.95K -47.01% $0.00 4.45K May 18, 2023 Direct F1, F3
transaction DXCM Common Stock Gift $0 +1.55K +29.66% $0.00 6.77K Aug 11, 2022 by Trust F1
transaction DXCM Common Stock Gift $0 +3.95K +58.33% $0.00 10.7K May 18, 2023 by Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred from direct ownership to ownership under the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, upon vesting of previously awarded restricted stock units.
F2 The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F3 Included in this number are 4,450 unvested restricted stock units, 2,906 of which were granted on May 18, 2023 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2024 Annual Meeting and 1,544 of which were granted on August 11, 2020 and shall vest through August 11, 2023.
F4 Shares are held by the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, with respect to which the reporting person is a trustee.